FP
NVNO

Financial Perspectives’s enVVeno Medical NVNO Stock Holding History

Financial Perspectives’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-94
Closed -$16.8K – 695
2023
Q4 		$16.8K Hold
94
– – 0.01% 400
2023
Q3 		$17.7K Hold
94
– – 0.01% 375
2023
Q2 		$10.1K Hold
94
– – ﹤0.01% 449
2023
Q1 		$15.3K Hold
94
– – 0.01% 394
2022
Q4 		$16.7K Hold
94
– – 0.01% 381
2022
Q3 		$20.6K Hold
94
– – 0.01% 345
2022
Q2 		$12.4K Hold
94
– – 0.01% 416
2022
Q1 		$20.9K Hold
94
– – 0.01% 366
2021
Q4 		$21.6K Hold
94
– – 0.01% 347
2021
Q3 		$34K Hold
94
– – 0.02% 283
2021
Q2 		$22.5K Sell
94
-530
-85% -$114K 0.01% 364
2021
Q1 		$3.28M Buy
+624
New +$174K 0.16% 102

Other funds holding NVNO

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Financial Perspectives's NVNO Position: Q1 2024 in Review

Financial Perspectives sold out of enVVeno Medical (NVNO) in Q1 2024, closing a stake of 94 shares — an estimated $16.8K sold.

Financial Perspectives first reported a position in NVNO in Q1 2021 and held it in 12 quarters. The position peaked at $3.28M in Q1 2021. 31 funds tracked by Wall St. Rank hold NVNO as of Q1 2024.

  • Financial Perspectives reported no remaining enVVeno Medical position as of Q1 2024 after selling out during the quarter.
  • Financial Perspectives sold 94 enVVeno Medical shares in Q1 2024, an estimated $16.8K.
  • Financial Perspectives first reported a position in enVVeno Medical in Q1 2021 and held it in 12 quarters.
  • Financial Perspectives's enVVeno Medical position peaked at $3.28M in Q1 2021.
  • 31 funds tracked by Wall St. Rank held enVVeno Medical as of Q1 2024.

Based on Financial Perspectives's 13F filing for Q1 2024, filed 19 Apr 2024.